|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-8-7
|
|
pubmed:abstractText |
Despite the accumulating evidence of their efficacy, angiotensin-converting enzyme inhibitors (ACEi) still provide imperfect renoprotection. Up-titration above conventional doses and combined therapy with other antiproteinuric agents may serve to achieve renoprotection in patients at risk of rapid disease progression.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0085-2538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1010-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12164885-Adolescent,
pubmed-meshheading:12164885-Adult,
pubmed-meshheading:12164885-Aged,
pubmed-meshheading:12164885-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12164885-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:12164885-Dextrans,
pubmed-meshheading:12164885-Drug Therapy, Combination,
pubmed-meshheading:12164885-Female,
pubmed-meshheading:12164885-Humans,
pubmed-meshheading:12164885-Indomethacin,
pubmed-meshheading:12164885-Kidney Failure, Chronic,
pubmed-meshheading:12164885-Kidney Glomerulus,
pubmed-meshheading:12164885-Male,
pubmed-meshheading:12164885-Middle Aged,
pubmed-meshheading:12164885-Proteinuria,
pubmed-meshheading:12164885-Ramipril
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effect of high dose ramipril with or without indomethacin on glomerular selectivity.
|
|
pubmed:affiliation |
Aldo & Cele Daccò Clinical Research Center for Rare Diseases, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
